Cilostazol improves long-term outcomes after coronary stent implantation - 21/08/11
Doi : 10.1016/j.ahj.2005.06.021
Yaling Han, MD a, ⁎ 
, Shouli Wang, MD a, Yi Li, MD a, Quanmin Jing, MD a, Yingyan Ma, MD a, Jie Deng, MD a, Guitang Yang, MD a, Haibo Yu, MD a, Junbo Ge, MD b
, Shouli Wang, MD a, Yi Li, MD a, Quanmin Jing, MD a, Yingyan Ma, MD a, Jie Deng, MD a, Guitang Yang, MD a, Haibo Yu, MD a, Junbo Ge, MD b a Department of Cardiology, Northern Hospital, Shenyang, China
b Department of Cardiology, Zhongshan Hospital, Shanghai, China
⁎Reprint requests: Yaling Han, MD, Department of Cardiology, Northern Hospital, 83 Wenhua Road, Shenyang, 110016, PR China.
Vol 150 - N° 3
P. 568.e1-568.e5 - settembre 2005 Ritorno al numero
Articolo precedente
- Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction
- Leonardo De Luca, Paola Proietti, Annalisa Celotto, Chiara Bucciarelli-Ducci, Giulia Benedetti, Angelo Di Roma, Gennaro Sardella, Igino Genuini, Francesco Fedele
- Temporal variation in inhospital mortality with percutaneous coronary intervention: A report from the National Heart, Lung and Blood Institute Dynamic Registry
- Warren K. Laskey, Faith Selzer, David R. Holmes, Robert L. Wilensky, Howard A. Cohen, David O. Williams, Kevin E. Kip, Katherine M. Detre, on behalf of the NHLBI Dynamic Registry Investigators
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?